Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate Efficacy and Safety of Extended Adjuvant Treatment With Letrozole in Postmenopausal Women With Hormone Receptor Positive Breast Cancer Who Have Completed 5 Years of Toremifene

NCT01072318 is registered in ClinicalTrials.gov with Korean Breast Cancer Study Group as lead sponsor.

NCT NCT01072318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01072318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate Efficacy and Safety of Extended Adjuvant Treatment With Letrozole in Postmenopausal Women With Hormone Receptor Positive Breast Cancer Who Have Completed 5 Years of Toremifene
Lead sponsor
Korean Breast Cancer Study Group
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2010
Completion date
January 31, 2014
Enrollment
495 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer